Genomind's
Leadership Team
Guiding our mission to bring innovation to precision medicine.
Executive Leadership Team
Maintaining our commitment to delivering compassionate care and innovative precision health technology solutions.
David S. Krause, MD
Chief Medical Officer
Dr. David Krause is Co-Chief Executive Officer and Chief Medical Officer at Genomind. Board certified in internal medicine, Dr. Krause has more than 25 years…
Chief Strategy Officer
As Chief Strategy and Corporate Development Officer, Ms. Kilroy is responsible for the development of the corporate strategy to develop…
David J. Robbins, PhD,
DABCC, MT(AAB)
Lab Director
Jon Levine
Daniel Dowd, PharmD
of Medical Affairs
Dr. Daniel Dowd is Genomind’s Senior Vice President of Medical Affairs. His responsibilities at Genomind include building and managing…
Scientific Advisory Board
Recognized globally as authorities and thought leaders in various facets of healthcare, our SAB members fuel growth with their collective knowledge.
Dr. Scott Aaronson specializes in treatment-resistant affective disorders. He is a thought leader in the areas of biological psychiatry, diagnosis…
MD, PhD
Dr. Kathleen Brady serves as the Vice President for Research at the Medical University of South Carolina (MUSC). She is an experienced clinical and translational…
Stephen V. Faraone
PhD
Dr. Stephen Faraone is a Distinguished Professor in the Departments of Psychiatry and Neuroscience & Physiology at SUNY Upstate Medical University…
MD
Dr. Maurizio Fava is Director of the Division of Clinical Research of the Massachusetts General Hospital (MGH) Research Institute, Executive Vice Chair of the Department…
MD
Dr. Anil Malhotra is the Director of Psychiatry Research at the Zucker Hillside Hospital in Glen Oaks, NY, Professor of Psychiatry and Behavioral Sciences at the…
David B. Nash
MD, MBAÂ
Dr. David Nash is Founding Dean Emeritus and the Dr. Raymond C. & Doris Grandon Professor of Health Policy at Thomas Jefferson University…Â
Dr. Roy Perlis’ clinical work and research is focused on difficult-to-treat or treatment resistant mood disorders, including major depressive disorder and bipolar disorder…
PharmD, BCPP
Dr. Stephen Saklad joins Genomind’s SAB as Clinical Professor of Pharmacotherapy, Adjoint Professor at the University of Texas School of Medicine…
MD, MSc
Dr. Naomi Simon is Professor of Psychiatry at NYU School of Medicine, Vice Chair for Research Faculty Development and Mentorship, and Director of the Anxiety…
MD, PhD
An author of over 425 articles and more than 1500 scientific presentations and abstracts, Dr. Stephen Stahl is an internationally recognized clinician…
PhD, ABPP
Dr. Mark Stein is the Director of PEARL Clinic/ADHD and Related Disorders Program at Seattle Children’s Hospital and an Investigator at Seattle Children’s…
Department of Medical Affairs
Our team of PharmD and PhD experts deliver guidance on pharmacology, treatment guidelines, and pharmacogenomics to ensure clinician success.
Senior Medical Science Liaison
Dr. Russell Amato received
his PhD in Pharmacology at Louisiana State University and has over a decade of experience in developing…
Dr. Harris Nguyen graduated from Temple University with a Doctorate of Pharmacy in 2018. Prior to Genomind, he worked at Parexel…
Dr. Gabriela Williams joined the clinical team at Genomind in 2020 and serves as the Medical Science Liaison in the Great Lakes…
Dr. Seema Patel is a Board Certified Psychiatric Pharmacist licensed to practice in North Carolina. Prior to joining the team at Genomind…
